Actively Recruiting
Liver Cancer Registry Platform
Led by iOMEDICO AG · Updated on 2025-05-01
1000
Participants Needed
1
Research Sites
381 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study with associated satellites, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with Hepatocellular Carcinoma (HCC) or Cholangiocarcinoma (CCC) in Germany.
CONDITIONS
Official Title
Liver Cancer Registry Platform
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Confirmed diagnosis of hepatocellular carcinoma (HCC) or cholangiocarcinoma (CCC) at early, intermediate, or advanced/metastatic stage
- Age 18 years or older
- Signed and dated informed consent before primary locoregional therapy or start of first systemic treatment for participation in the patient-reported outcomes (PRO) module
- Signed and dated informed consent no later than 8 weeks after primary locoregional therapy or start of first systemic treatment if not participating in the PRO module
You will not qualify if you...
- Patients receiving only best supportive care without surgery, radiotherapy, ablative procedures, or systemic anti-tumoral treatments
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Multiple sites all over germany
Multiple Locations, Germany
Actively Recruiting
Research Team
I
iOMEDICO AG
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here